PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kordbacheh, T. [1 ,2 ]
Chan, C. [1 ]
Bossons, A. [2 ,3 ]
Franks, K. [4 ]
McDonald, F. [5 ]
Forster, M. [6 ]
Mendes, R. [7 ]
Quezada, S. [8 ]
Dovedi, S. [9 ]
Ralph, C. [10 ]
Popat, S. [11 ]
Harrington, K. [12 ,13 ]
Melcher, A. [14 ]
Popple, A. [9 ]
Illidge, T. [9 ]
Faivre-Finn, C. [1 ,2 ]
机构：
[1] Christie NHS Fdn Trust, Clin Oncol, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Clin Trials Unit, Manchester, Lancs, England
[4] St James Univ Hosp, Leeds Canc Ctr, Clin Oncol, Leeds, W Yorkshire, England
[5] Royal Marsden NHS Fdn Trust, Clin Oncol, London, England
[6] UCL, Oncol, London, England
[7] Univ Coll London Hosp, Clin Oncol, London, England
[8] UCL Canc Inst, Immune Regulat & Tumour Immunotherapy, London, England
[9] Canc Res UK Manchester Inst, Targeted Therapy, Manchester, Lancs, England
[10] Univ Leeds, Leeds Immunotherapy Team, Leeds, W Yorkshire, England
[11] Royal Marsden Hosp, Lung Oncol Unit, London, England
[12] Royal Marsden NHS Fdn Trust, Clin Oncol, Targeted Therapy, Manchester, Lancs, England
[13] Inst Canc Res, Manchester, Lancs, England
[14] Inst Canc Res, Translat Immunol, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [31] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Hasegawa, Yoshikazu
    Okamoto, Isamu
    Takezawa, Ken
    Miyazaki, Masaaki
    Tsurutani, Junji
    Yonesaka, Kimio
    Morinaga, Ryotaroh
    Tsuya, Asuka
    Terashima, Masaaki
    Kudoh, Toshihiro
    Azuma, Koichi
    Kurata, Takayasu
    Nishikawa, Tatsuyuki
    Fukuoka, Masahiro
    Nishimura, Yasumasa
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 599 - 604
  • [32] Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
    Zeng, Tian
    Qin, Qin
    Bian, Zhiheng
    Li, Jianjun
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 4194 - 4201
  • [33] Clinical Characteristics of Acquired Resistance with Anti-PD-1/PD-L1 in Non-Small Cell Lung Cancer (NSCLC)
    Shah, Shalin
    Wood, Kevin
    Brisson, Ryan
    Karrison, Theodore
    Hensing, Thomas
    Luke, Jason J.
    Patel, Jyoti D.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S310 - S310
  • [34] Multicenter phase II study of cetuximab (C) with concomitant radiotherapy (RT) followed by consolidation chemotherapy (CT) in locally advanced non-small cell lung cancer (NSCLC).
    Kotsakis, A. P.
    Ramalingam, S. S.
    Tarhini, A. A.
    Heron, D. E.
    Smith, R.
    Friedland, D.
    Petro, D. P.
    Raez, L. E.
    Brahmer, J. R.
    Greenberger, J. S.
    Dacic, S.
    Hershberger, P.
    Landreneau, R. J.
    Belani, C. P.
    Luketich, J. D.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC).
    Patel, S. H.
    Ajlouni, M.
    Chapman, R.
    Lu, M.
    Kim, J.
    Movsas, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 400S - 400S
  • [36] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    LUNG CANCER, 2005, 49 : S166 - S167
  • [37] Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer
    Sacco, Paola Claudia
    Maione, Paolo
    Rossi, Antonio
    Bareschino, Maria Anna
    Schettino, Clorinda
    Guida, Cesare
    Elmo, Massimo
    Ambrosio, Rita
    Barbato, Valentina
    Zeppa, Rosario
    Palazzolo, Giovanni
    Gridelli, Cesare
    TARGETED ONCOLOGY, 2011, 6 (03) : 171 - 180
  • [38] Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer
    Rajan, Arun
    Gray, Jhanelle E.
    Devarakonda, Siddhartha
    Birhiray, Ruemu
    Korchin, Borys
    Menius, Erika
    Donahue, Renee N.
    Schlom, Jeffrey
    Gulley, James L.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (03) : 447 - 457
  • [39] Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer
    Paola Claudia Sacco
    Paolo Maione
    Antonio Rossi
    Maria Anna Bareschino
    Clorinda Schettino
    Cesare Guida
    Massimo Elmo
    Rita Ambrosio
    Valentina Barbato
    Rosario Zeppa
    Giovanni Palazzolo
    Cesare Gridelli
    Targeted Oncology, 2011, 6 : 171 - 180
  • [40] Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a meta-analysis
    Jia, Minghan
    Feng, Weijiao
    Kang, Shiyang
    Zhang, Yaxiong
    Shen, Jianfei
    He, Jiaxi
    Jiang, Long
    Wang, Wei
    Guo, Zhihua
    Peng, Guilin
    Chen, Gang
    He, Jianxing
    Liang, Wenhua
    JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : 455 - 461
12345